Get the Stockscreener App
77.32
0.55%
-0.41
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Ventas Inc stock is traded at $77.32, with a volume of 1.37M.
It is down -0.55% in the last 24 hours and up +1.48% over the past month.
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
See More
Previous Close:
$77.73
Open:
$77.73
24h Volume:
1.37M
Relative Volume:
0.47
Market Cap:
$36.32B
Revenue:
$5.56B
Net Income/Loss:
$247.25M
P/E Ratio:
146.13
EPS:
0.5291
Net Cash Flow:
$1.24B
1W Performance:
-3.92%
1M Performance:
+1.48%
6M Performance:
+21.91%
1Y Performance:
+27.31%
1-Day Range:
$76.14
$77.84
1-Week Range:
$76.14
$81.89
52-Week Range:
$56.68
$81.89
Ventas Inc Stock (VTR) Company Profile
Name
Ventas Inc
Sector
Industry
Phone
(312) 660-3800
Address
300 N LASALLE STREET, CHICAGO, IL
Compare VTR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
77.33 | 36.51B | 5.56B | 247.25M | 1.24B | 0.5291 |
|
WELL
Welltower Inc
|
187.21 | 131.14B | 9.90B | 967.82M | 1.88B | 1.3269 |
|
OHI
Omega Healthcare Investors Inc
|
44.22 | 13.14B | 1.08B | 448.00M | 779.91M | 1.61 |
|
DOC
Healthpeak Properties Inc
|
16.68 | 11.56B | 2.80B | 279.29M | 1.20B | 0.40 |
|
AHR
American Healthcare Reit Inc
|
46.82 | 8.57B | 2.07B | -37.81M | 84.15M | -0.27 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-19-25 | Initiated | UBS | Neutral |
| Jun-23-25 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-07-25 | Upgrade | Argus | Hold → Buy |
| Jan-17-25 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-01-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Feb-26-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-30-24 | Initiated | Deutsche Bank | Buy |
| Jan-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-07-23 | Upgrade | Wedbush | Neutral → Outperform |
| Oct-11-23 | Initiated | Exane BNP Paribas | Outperform |
| Oct-03-23 | Initiated | Wedbush | Neutral |
| Sep-20-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-11-23 | Downgrade | BofA Securities | Buy → Neutral |
| Jun-23-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-20-23 | Initiated | Wells Fargo | Overweight |
| Nov-01-22 | Reiterated | Credit Suisse | Outperform |
| Nov-01-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-10-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jun-30-22 | Upgrade | Jefferies | Hold → Buy |
| Jun-23-22 | Initiated | Credit Suisse | Outperform |
| Jun-03-22 | Initiated | CapitalOne | Overweight |
| May-18-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-11-22 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Mar-11-22 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-01-22 | Initiated | Credit Suisse | Neutral |
| Jan-20-22 | Upgrade | Mizuho | Neutral → Buy |
| Dec-14-21 | Upgrade | Citigroup | Neutral → Buy |
| Nov-22-21 | Downgrade | SMBC Nikko | Outperform → Neutral |
| Oct-04-21 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-23-21 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-07-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Aug-26-21 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| Jul-14-21 | Resumed | Mizuho | Neutral |
| Jun-15-21 | Initiated | Wolfe Research | Outperform |
| Jun-11-21 | Upgrade | Barclays | Equal Weight → Overweight |
| May-13-21 | Upgrade | KeyBanc Capital Markets | Underweight → Overweight |
| May-13-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-08-21 | Downgrade | BMO Capital Markets | Market Perform → Underperform |
| Jan-06-21 | Initiated | Robert W. Baird | Neutral |
| Nov-30-20 | Upgrade | BofA Securities | Underperform → Buy |
| Nov-10-20 | Upgrade | Jefferies | Underperform → Hold |
| Sep-08-20 | Downgrade | Argus | Buy → Hold |
| Sep-02-20 | Resumed | Stifel | Hold |
| Aug-20-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-14-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-14-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jun-15-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Mar-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Mar-23-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Mar-10-20 | Downgrade | Jefferies | Buy → Underperform |
| Feb-28-20 | Upgrade | Raymond James | Underperform → Mkt Perform |
| Jan-22-20 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-17-20 | Upgrade | Jefferies | Hold → Buy |
| Dec-20-19 | Resumed | Mizuho | Neutral |
| Dec-10-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Nov-19-19 | Upgrade | Argus | Hold → Buy |
| Oct-30-19 | Downgrade | Stifel | Buy → Hold |
| Oct-28-19 | Downgrade | CapitalOne | Overweight → Equal Weight |
| Oct-28-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Ventas Inc Stock (VTR) Latest News
Ventas, Inc. (NYSE:VTR) Declares $0.48 Quarterly Dividend - MarketBeat
Key Reasons to Add Ventas Stock to Your Portfolio Right Now - TradingView
Qube Research & Technologies Ltd Grows Holdings in Ventas, Inc. $VTR - MarketBeat
Does Ventas Still Offer Value After Its Strong 2025 Run and DCF Implied Upside? - simplywall.st
State Street Corp Buys 1,388,678 Shares of Ventas, Inc. $VTR - MarketBeat
Is Ventas Stock Outperforming the S&P 500? - Barchart.com
First Trust Advisors LP Raises Holdings in Ventas, Inc. $VTR - MarketBeat
Arrowstreet Capital Limited Partnership Reduces Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas Maintains Quarterly Dividend at $0.48 per Share, Payable Jan. 15, 2026, to Holders of Record Dec. 31 - marketscreener.com
Ventas declares quarterly dividend of $0.48 per share By Investing.com - Investing.com Canada
Ventas declares quarterly dividend of $0.48 per share - Investing.com India
Ventas Declares Quarterly Dividend of $0.48 Per Common Share - Caledonian Record
Ventas (NYSE:VTR) Hits New 52-Week HighTime to Buy? - MarketBeat
Ventas Inc. Stock Outperforms Competitors Despite Losses On The Day - 富途牛牛
Ventas, Inc. $VTR Shares Acquired by GRS Advisors LLC - MarketBeat
Investment Management Corp of Ontario Boosts Holdings in Ventas, Inc. $VTR - MarketBeat
Natixis Buys New Holdings in Ventas, Inc. $VTR - MarketBeat
Jump Financial LLC Has $9.74 Million Stock Position in Ventas, Inc. $VTR - MarketBeat
Ventas, Inc. $VTR Stock Holdings Trimmed by Daiwa Securities Group Inc. - MarketBeat
California Public Employees Retirement System Cuts Stock Position in Ventas, Inc. $VTR - MarketBeat
Amundi Buys 67,438 Shares of Ventas, Inc. $VTR - MarketBeat
Healthpeak, Omega, Ventas share investor updates - McKnight's Senior Living
Ventas : 2025 Nareit REITworld Conference - marketscreener.com
Ventas stock hits all-time high at 81.31 USD By Investing.com - Investing.com South Africa
Ventas stock hits all-time high at 81.31 USD - Investing.com
Raymond James Adjusts Price Target on Ventas to $90 From $78, Maintains Outperform Rating - marketscreener.com
Ventas, Inc. $VTR Shares Purchased by Marshall Wace LLP - MarketBeat
Top 2 Real Estate Stocks That May Collapse This Month - Benzinga
Should Ventas’ (VTR) $500 Million Notes Issuance Require Action From Healthcare REIT Investors? - simplywall.st
Invesco Ltd. Raises Holdings in Ventas, Inc. $VTR - MarketBeat
Quantbot Technologies LP Acquires 27,738 Shares of Ventas, Inc. $VTR - MarketBeat
423,999 Shares in Ventas, Inc. $VTR Bought by Epoch Investment Partners Inc. - MarketBeat
Ventas to Participate in Investor Meetings at Nareit’s REITworld 2025 Annual Conference - Bakersfield.com
Ventas (NYSE:VTR) Sets New 12-Month HighStill a Buy? - MarketBeat
SCS Capital Management LLC Invests $13.79 Million in Ventas, Inc. $VTR - MarketBeat
How Ventas Inc. stock valuations compare to rivalsBear Alert & Risk Adjusted Buy/Sell Alerts - Newser
Why Ventas Inc. stock is a strong buy call2025 Investor Takeaways & AI Enhanced Trading Signals - Newser
Keybanc Maintains Ventas (VTR) Overweight Recommendation - Nasdaq
Ventas announces pricing of $500M senior notes offering - MSN
Ventas Realty Issues $500M in Senior Notes - TipRanks
Keybanc Raises Price Target for Ventas (VTR) to $85.00 | VTR Sto - GuruFocus
KeyBanc Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $85 - 富途牛牛
KeyBanc Adjusts Price Target on Ventas to $85 From $70, Maintains Overweight Rating - marketscreener.com
How forex fluctuations impact Ventas Inc. stock2025 Risk Factors & Weekly Watchlist for Consistent Profits - Newser
Ventas, Inc. $VTR Shares Purchased by 1832 Asset Management L.P. - MarketBeat
Form 424B2 Ventas, Inc. - StreetInsider
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
749,803 Shares in Ventas, Inc. $VTR Bought by Panagora Asset Management Inc. - MarketBeat
Mackenzie Financial Corp Sells 148,925 Shares of Ventas, Inc. $VTR - MarketBeat
How Ventas Inc. stock reacts to Fed tighteningMarket Activity Summary & Free Daily Entry Point Trade Alerts - Newser
Ventas Subsidiary Prices Public Offering Of $500.0 Mln Of 5.000% Senior Notes Due 2036 - Nasdaq
Ventas Inc Stock (VTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.60%
0.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):